Company intelligence / Profile preview
Amphastar France Pharmaceuticals
Eragny-sur-Epte, France
- Ownership
- Private
- Development stage
- Other
01
Overview
Amphastar France Pharmaceuticals is the French subsidiary of Amphastar Pharmaceuticals, producing commercial insulin APIs, recombinant human insulin, and various finished dosage forms. Its facility in Eragny-sur-Epte has a strong regulatory/cGMP compliance record and supports the parent company’s global commercial and pipeline products, including BAQSIMI (glucagon nasal powder), Primatene Mist (inhaled epinephrine), insulin APIs, and others.[11][13]
- Therapeutic areas
- EndocrinologyPulmonology
- Modalities
- Small moleculeProteinRecombinant proteinBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Amphastar France Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amphastar France Pharmaceuticals.